Guj. Inject(Ker)

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE659F01014
  • NSEID:
  • BSEID: 524238
INR
115.00
-1.1 (-0.95%)
BSENSE

Jun 11, 03:40 PM

BSE+NSE Vol: 21.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'17
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 229.04% vs 3,231.11% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2,296.42% vs 111.90% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 227.70% vs 787.62% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 1,129.03% vs 101.63% in Mar 2024

Compare Profit and Loss Results of Guj. Inject(Ker)
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
19.00
115.00
-96.00
-83.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
19.00
115.00
-96.00
-83.48%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
3.00
-3.00
-100.00%
Raw Materials Consumed
17.00
49.00
-32.00
-65.31%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
0.00
14.00
-14.00
-100.00%
Operating Expenses
0.00
4.00
-4.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2.00
-2.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
17.00
88.00
-71.00
-80.68%
Operating Profit (PBDIT) excl Other Income
1.00
26.00
-25.00
-96.15%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
1.00
35.00
-34.00
-97.14%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
1.00
35.00
-34.00
-97.14%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
1.00
33.00
-32.00
-96.97%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
32.00
-31.00
-96.88%
Provision for Tax
0.00
8.00
-8.00
-100.00%
Profit After Tax
1.00
24.00
-23.00
-95.83%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
147.00
-147.00
-100.00%
Profit Available for appropriations
1.00
171.00
-170.00
-99.42%
Appropriations
1.00
171.00
-170.00
-99.42%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.13
67.61
-66.48
-98.33%
Profit And Loss - Net Sales
Net Sales 19.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 229.04% vs 3,231.11% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2,296.42% vs 111.90% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 227.70% vs 787.62% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1,129.03% vs 101.63% in Mar 2024